The last full week of January 2018 featured plenty of captivating cannabis news — including Vermont becoming the newest recreationally legal state!
Here’s a new rule for cannabis news watchers in 2018: Don’t blink. But if you did this past week, don’t worry, we’ve got you covered. Here are some of the bigger ticket cannabis news items.
Vermont goes recreationally legal
The Green Mountain State, indeed! After nearly joining the recreational ranks in 2017, Vermont became the first state to legalize recreational marijuana through their legislature on Monday when Gov. Phil Scott signed House Bill 511 into law. Beginning July 1, 2018 Vermont residents will be able to grow their own cannabis and possess small amount for personal use.
Is marijuana flower power dwindling? Yes
The New York Times ran a story on the front page of their business section Wednesday highlighting the decreasing consumer appeal of marijuana flower. Consumers have, especially over the past year, shown an increasing interest in other forms of cannabis products. A recent Eaze consumer study bolsters the NYT piece. According to Eaze, vaporizer products are cutting into flower popularity the most.
Marijuana media attention is booming
Gone are the days of relying on industry-specific media outlets for cannabis news and information. Nowadays, mainstream outlets are dedicating more type space to marijuana than ever before. Just this week, the Associated Press announced the formation of a dedicated marijuana editorial team comprised of seven reporters, two video journalists, and a photographer.
Georgia makes encouraging MMJ dispensary moves
It’s no secret that southeastern states haven’t been the most friendly to marijuana — recreational or medical. Georgia, however, looks to be taking steps in the right direction medically speaking, as an MMJ dispensary bill was approved Wednesday by a House review group. The bill, if signed into law, would allow for limited cannabis cultivation, and up to 10 medical dispensaries in the state.
A cannabis-based anti-seizure medicine may come to market soon
GW Pharmaceuticals released results this week from study conducted on seizure-suffering patients with Lennox-Gastaut syndrome. Participants were given a new drug with ingredients derived from cannabis — and the results were favorable. According to the lead author of the study, “For some, it (cannabis) does not do a whole lot. But for the people it does work in, it is priceless.”
Allllllllllrighty then. We’re always happy to give you some cannabis news headlines that you can share at your next dinner party.
Come back next week for more.